Centers for Medicare and Medicaid Services issued the following announcement on July 2.Today, the Centers for Medicare & Medicaid Services (CMS) proposed significant changes to the Home Health Prospective Payment System to strengthen and modernize Medicare, drive value, and focus on individual patient needs rather than volume of care.

The Senate health committee today passed legislation sponsored by Senator Lamar Alexander (R-Tenn.) and Senator Michael Bennet (D-Colo.) to reduce infant deaths and improve infant health by continuing research and education programs aimed at preventing preterm births.

Two discoveries — one in the brains of people with heroin addiction and the other in the brains of sleepy mice — shed light on chemical messengers in the brain that regulate sleep and addiction, UCLA researchers say.

Stress hormones can save lives, or take them.

Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.

A drug used to help kidney transplant recipients ward off rejection of their new organs is showing promise in another area: preserving insulin production in newly diagnosed Type 1 diabetes patients.

Following an extensive analysis of published studies, researchers at the University of Colorado Anschutz Medical Campus have found that while suicide rates are higher at higher altitudes, they are unlikely caused by hypoxia, (low oxygen) at these elevations.

As we age, our ability to adequately respond to summer heat can become a serious problem.

A major study has found that medicines used to treat diabetes in adults are not effective on youth.

Today the Department of Labor issued final rules governing the creation of association health plans (AHP).

Reviewing medical information gathered on more than 6,000 adults over a 10-year period, Johns Hopkins researchers have found that lower than normal blood levels of vitamin D were linked to increased risk of early signs of interstitial lung disease (ILD).

Researchers funded by the National Institutes of Health have shown that a therapy-based treatment for disruptive behavioral disorders can be adapted and used as an effective treatment option for early childhood depression.

More than 90 percent of people diagnosed with lung cancer do not survive the disease, in part because it is often found at an advanced stage.

The AMA House of Delegates has adopted new policy opposing so-called lockout provisions that block Medicaid patients from the program for lengthy periods.

Takeda today announced its U.S. Business Unit will further expand its patient assistance program to help more patients access their medications.

Ways and Means Committee Chairman Kevin Brady (R-TX), Energy and Commerce Committee Chairman Greg Walden (R-OR), Ways and Means Committee Ranking Member Richard Neal (D-MA), and Energy and Commerce Committee Ranking Member Frank Pallone, Jr. (D-NJ) today released the following statement after introduction of H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

Flavor additives used in electronic cigarettes and related tobacco products could impair blood vessel function and may be an early indicator of heart damage, according to new laboratory research in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart Association journal.

To help consumers navigate information about popular herbs and herbal supplements, the National Institutes of Health’s National Center for Complementary and Integrative Health has launched HerbList™ – an app for research-based information about the safety and effectiveness of herbal products.

Today, the House and Senate released the new bipartisan, bicameral agreement on the Synthetics Trafficking and Overdose Prevention (STOP) Act, legislation to help prevent the shipment of synthetic opioids into the United States through the international mail system.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.